Pre-Filled Syringe Cell Therapy Delivery Systems Market
Key Insight
FMI opines the Pre-Filled Syringe Cell Therapy Delivery Systems Market was valued at USD 145.0 million in 2025. Sales are expected to reach USD 160.4 million in 2026 and USD 424.4 million by 2036. COP/COC polymer syringes are poised to lead by Material Type with 58.0% share in 2026, and Ready-to-use (RTU) nested systems are estimated to dominate by Sterility / Supply Format through 2036.